1.
Malisorn N. New promising agents, boceprevir and telapevir, for new standard care for the treatment of chronic HCV infection. J Basic App Pharmacol [Internet]. 2015 Mar. 18 [cited 2026 Nov. 19];35(1):41-54. Available from: https://li01.tci-thaijo.org/index.php/JBAP/article/view/32172